高分文献速递
客户单位:东南大学
期刊:Bioactive Materials
影响因子(IF):20.3
文章题目:
Metabolic modulation-driven self-reinforcing pyroptosis-STING nanoadjuvant for potentiated metalloimmunotherapy
文章摘要:
Pyroptosis is a critical process that triggers inflammatory responses and mitochondrial DNA (mtDNA) release, thereby activating the cGAS-STING pathway. However, tumor metabolism, particularly glycolysis, often suppresses immune activation. To address this, we developed GOCoF2, a self-amplifying pyroptosis-STING nanoadjuvant that integrates glucose oxidase (GOx) with cobalt fluoride (CoF2) nanoenzymes. This nanoadjuvant excelled in converting intratumoral H2O2 into reactive oxygen species (ROS), inducing cell pyroptosis. Its self-sustaining mechanism involved glucose depletion and continuous H2O2 generation, ensuring persistent catalytic activity. This metabolic manipulation and induction of oxidative stress significantly enhance pyroptosis in tumor cells. The released mtDNA subsequently activated the cGAS-STING pathway, with Co2+ further amplifying this effect. Notably, glucose-dependent TREX2 inhibition intensified cGAS-STING activation through metabolic regulation, leading to a strong immune response and tumor growth suppression. When combined with immune checkpoint blockade therapy, GOCoF2 significantly inhibited primary and distant tumor progression via systemic immune activation. Additionally, we formulated GOCoF2-lipiodol for transarterial embolization, which demonstrated superior efficacy in a rat model of orthotopic hepatocellular carcinoma. This study not only sheds light on the intricate relationship between tumor metabolism and immune regulation but also introduces a novel therapeutic approach for hepatocellular carcinoma.
原文链接:
https://doi.org/10.1016/j.bioactmat.2025.07.040
引用产品及培养细胞:FBS-303 H22,N1S1
SCI
助力科研·一路同行
2025 SCI论文奖励活动全新升级
|
影响因子(IF) |
新奖励方案 |
升级体验 |
|
IF<20 |
¥50元京东卡 |
①赠送常规科研用细胞1株(STR鉴定正确) ②额外获得「科研助力礼包」 (含有优先供货 + 技术咨询快速通道) |
|
IF≥20 |
¥2000元京东卡 |
①赠送常规科研用细胞1株(STR鉴定正确) ②额外获得「科研助力礼包」 (含有优先供货 + 技术咨询快速通道) ③授予 "年度科研协作伙伴" 称号 |
注:影响因子(IF)以2025年公布的数据为准
细胞清单,扫码查看
· ·奖励对象及规则 · ·
(新计划活动时间 )
2025年05月01日-2025年12月31日
1.奖励对象
使用金源康生物胎牛血清产品FBS-300、FBS-301、FBS-303,并在SCI期刊杂志发表文章,且文章正文中在使用产品的位置标注相应产品型号及我公司名“Inner Mongolia Jinyuankang Biotechnology Co., Ltd”或“Jin Yuan Kang Biotechnology”均可参与本次活动。
2. 奖励说明
1) 申请人论文已发表三个月内,且为第一作者或通讯作者,第一作者与通讯作者同时申请,以通讯作者为准;同一申请人若有多篇见刊论文引用同一产品,则按最高影响因子所在档实施单次最大奖励,不予重复奖励;
2) 提供文献全文(PDF格式)以及文章链接,并同意在金源康及其旗下子品牌后续推广展示;
3) 每篇文献仅限领取一次奖励;
4) 影响因子(IF)以申请奖励时间为准;
5) 试用装产品,不参与活动奖励;
6) 经公司审核通过后,我们会尽快与申请人联系,确定购物卡及赠送细胞的派发。
· ·活动参与方式 · ·
参与方式一
扫描下方二维码,填写问卷,7个工作日内,工作人员将与您联系。
完整填写信息丨申请文献奖励
参与方式二
扫描下方二维码,关注“金源康生物”微信公众号。
“金源康生物”微信公众号
回复“文献奖励”关键词,弹出问卷链接,完成问卷填写并提交。
参与方式三
关注“金源康生物”微信公众号,点击如图所示【文献奖励报名】菜单栏,可直接申请。
;
更多文献奖励活动详情,点击:助力科研,一路同行 | 2025 SCI论文奖励活动全新升级

